Literature DB >> 1733073

Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification.

R J Knight1, A Vathsala, L Schoenberg, S Camel, R B Weinberg, R A Goldstein, R M Lewis, C T van Buren, B D Kahan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1733073

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

Review 1.  Primary care of the renal transplant patient.

Authors:  J D Pirsch; R Friedman
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

Review 2.  Choosing the right lipid-regulating agent. A guide to selection.

Authors:  J A Farmer; A M Gotto
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 3.  Prevention and management of the adverse effects associated with immunosuppressive therapy.

Authors:  S J Rossi; T J Schroeder; S Hariharan; M R First
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

Review 4.  Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.

Authors:  C M Spencer; L B Barradell
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.